Caldwell Sutter Capital »

Brainstorm Cell Therapeutics shares owned by Caldwell Sutter Capital

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Caldwell Sutter Capital from 13F filings

Historical chart of Caldwell Sutter Capital investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Caldwell Sutter Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Caldwell Sutter Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 157k 0.00
2023-12-31 $0 157k 0.00
2023-09-30 $0 157k 0.00
2023-06-30 $0 157k 0.00
2023-03-31 $0 157k 0.00